גאלבוס 50 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

VILDAGLIPTIN 50 MG

Dostupné s:

NOVARTIS PHARMA SERVICES AG

ATC kód:

A10BH02

Léková forma:

TABLETS

Podání:

PER OS

Výrobce:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapeutické skupiny:

VILDAGLIPTIN

Terapeutické indikace:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Datum autorizace:

2008-12-01